Objective: Objective of the present analytical research work was to develop and validate Spectrophotometric method and High Performance Liquid Chromatographic method (HPLC Method) for the Apremilast bulk and tablets dosage form.
INTRODUCTION
According to recent study no treatment can cure psoriasis but Apremilast can control signs and symptoms of psoriasis. Apremilast is a class of phosphodiester-4 inhibitor used in treatment of rheumatic arthritis and psoriatic arthritis. It is act as an anti-inflammatory caused by these conditions. Phosphodiesterase inhibitor is a cyclic adenosine monophosphate which is predominantly located in inflammatory cells and by inhibiting PDE-4 it increases intracellular level of cAMP which further inhibits proinflammatory mediators including interleukin-2, interferon gamma, TNF-alpha, PDE-4. Figure 1 : Structure of Apremilast By chemically Apremilast is N-[2-[(1S)-1-(3-ethoxy-4methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3dioxo-1H-isoindol-4-yl]acetamide with molecular formula and weight of C22H24N2O7S and 460.5 g/mole respectively. This analysis method follows ICH validation guidelines. This current research tries to develop new rapid, effective method for determination of Apremilast in bulk form according to ICH Q2 R1 guidelines.
MATERIALS AND METHODS

Chemicals and Reagents
Analytically pure samples of Apremilast were kindly supplied by Hetero Drugs Limited., Water (HPLC Grade) and MeOH (AR grade ) Merck specialities private limited, Mumbai
Instrument Used
Electronic Weighing Balance (Shimadzu AY-220), Ultrasonicator (Wenser pvt ltd PGB-100), Cellulose Acetate Filter, 0.45 µm (Nylon 66), HPLC System (Analytical Technologies),UV VIS Spectrophotometer (Shimadzu UV-1800)
Spectrophotometric Method
Development of Spectrophotometric Method
Selection of Solvent
Solutions of APR (1000 µg/ml) was prepared in different solvents like methanol and water. These solutions were scanned in UV-Visible Region (200 nm to 800 nm) and intensity of absorption and wavelength of absorption were studied.
Preparation of Standard Stock Solution
Standard stock solution was prepared.
Selection of Wavelength Range
From the stock solutions, 0.1 ml of APR was transferred to 10 ml volumetric flask and the volume was adjusted to the mark with MeOH to obtain Strength 10µg/ml. The solution was scanned in the UV range 200-400 nm.
Fig 2. UV spectra of Apremilast
Preparation for Calibration Curve
Calibration curve were prepared and graph was plotted.
Analysis of Tablets
For analysis of commercial formulation, twenty tablets were weighed, average weight determined and crushed into fine powder. An accurately weighed quantity of powder equivalent to 10 mg of APR was transferred into 10 ml volumetric flask containing 5 ml methanol, shaken manually for 10 min, volume was adjusted to mark with same solvent and filtered through Whatman filter paper. The absorbance of sample solution was recorded at recorded at 230 nm.
Validation of Spectrophotometric Method Linearity and Range
The linearity of analytical method for APR was determined by studying standard calibration curves. The range of analytical method was decided from the interval between upper and lower level of calibration curves by plotting the log curve.
Accuracy
Accuracy of the method was assessed by standard addition method at three different concentration levels i.e. 50%, 100, 150. Standard concentration of 2,4, and 6 µg/ml was added into 4 µg/ml of tablet concentration. The % recovery was then calculated by using formula 
Precision
The precision of an analytical method was studied by performing intermediate precision.
Intra-day Precision
Intra-day precision was determined by analyzing the 2,4,6 µg/ml of APR for three times in the same day.
Inter-day Precision
Inter-day precision was determined by measuring the the 2,4,6 µg/ml of APR for three consecutive days.
Limit of Detection (LOD) and Limit of Quantitation (LOQ)
Detection limit and quantitation limit were determined based on the standard deviation of yintercepts of calibration curves and average slope of calibration curves.
LOD = 3.3 × Standard deviation of intercept Slope
LOD = 10× Standard deviation of intercept Slope
Ruggedness
Ruggedness of the method was checked by two different analysts keeping same experimental and environmental conditions. An appropriate concentration 4,8 µg/ml of APR was subjected to analysis and concentration was determined. This procedure was repeated three times.
Chromatographic Method
Development of Chromatographic method Description
The sample of Apremilast was observed for its color and texture.
Solubility
The sample of Apremilast was taken in test tubes and observed for solubility in various solvents like alcohol and water.
ISSN: 2250-1177 [138] CODEN (USA): JDDTAO
Selection of Mobile Phase
The selection was made on the basis of literature survey. After assessing the solubility of drug in different solvents as well on the basis of literature survey, Methanol and water were selected as a first choice.
Selection of Analytical Wavelength
To investigate the appropriate wavelength for determination of APR, the solution of the same in the MeOH were scanned separately by UV-Visible spectrophotometer in the range of 190-400 nm and the spectrum were recorded.
Preparation of Mobile Phase
Mobile Phase A: HPLC grade MeOH was degassed in sonicator for 15 min.
Mobile Phase B: HPLV grade water
Preparation of Standard Stock Solution
Standard stock solution was prepared by dissolving 10 mg of Apremilast in 10 ml methanol that gives concentration of 1000 g/ml of Apremilast and labeled as Standard stock Apremilast.
Preparation of Calibration Curve
Analysis of tablets
To determine the content of APR in conventional tablets; the twenty tablets were weighed, their mean weight determined and they were finely powered and powder equivalent 10.0 mg APR was transferred into a 10 mL volumetric flask containing 5 mL methanol, sonicated for 30 min and diluted to 1000 mL with methanol. The resulting solution was filtered, using 0.22 µm filter and 30 µg/mL was injected into system. The amount of APR was determined. The assay procedure was repeated for six times and Calculated using following equation.
Ct= Rt × Cs Rs
Where, Ct and Cs = Concentration of Sample and Standard Solution, respectively. Rt and Rs = Peak Area for Sample and Standard Solution, respectively.
Validation of HPLC Method Linearity
Accuracy
Accuracy of the method was assessed by standard addition method at three different concentration levels i.e. 50%, 100, 150%. Standard concentration of 10,20 and 30 µg/ml was added into 20 µg/ml of tablet concentration. The % Recoveries was calculated by applying regression equation.
Precision
Intra-day Precision
Intra-day precision was determined by analyzing the standard solutions of APR (10,30,50 µg/ml) and at three different time intervals on same day.
Inter-day Precision
Inter-day precision was determined by analyzing the combined standard solution of Apremilast (10,30,50 µg/ml) on three consecutive days. The results were reported in terms of % RSD.
Limit of Detection and Limit of Quantitation
LOD = 3.3 × Standard deviation of intercept Slope
LOD = 10× Standard deviation of intercept Slope
Robustness
Standard solution of APR (30 µg/ml)) were used and analyzed at different flow rate (0.7,0.8,0.9 ml/min) and wavelength (228,230,232 nm).
Ruggedness
Ruggedness of the method was checked by two different analysts keeping same experimental and environmental conditions. An appropriate concentration 30 µg/ml of APR was subjected to analysis and concentration was determined. This procedure was repeated three times.
System Suitability
Standard solution of APR (30 µg/ml) was prepared and analyzed. Chromatograms were studied for different parameters such as tailing factor, resolution and theoretical plates to see that whether they complies with the recommended limit or not.
RESULT AND DISCUSSION
UV-Visible Spectrophotometric Methods
Linearity study
Standard solution having concentration range of 2,4,6,8,10 µg/ml of APR was prepared. Absorbances of these solutions were recorded at 230 nm. Calibration curve was plotted, absorbance vs concentration. Fig 3, Table 1 . 
Assay of Marketed Formulation
Using this method, the marketed formulation was analyzed. Sample solution containing 6 µg/ml. The amount of drug present in the marketed formulation was calculated .The mean % assay of APR was found to be 99.82%. Table 3 . 
Validation Parameters
Validation of the method was performed in accordance to ICH guidelines. Accuracy of the method was determined at 50%, 100% and 150% level by standard addition method and percentage recovery APR were found to be in the range of 99.93 -100.29 %. Precision of the method was determined by % RSD of intra-day precision, inter-day precision. It was found to be less LOD and LOQ of APR was found to be 0.0424 and 0.1286 µg/ml, respectively. 
Chromatographic Method
Selection of Analytical Wavelength
The standard solutions of APR (10 µg/ml) in mobile phase were scanned in the UV region of 190 -400 nm and the overlain spectra were recorded. It was observed that APR drugs showed the absorbance at 230 nm. So, the wavelength of detection used was 230 nm. 
Mobile phase
Linearity Study
APR was found to be linear in the concentration range of 10-50 µg/ml. Fig 5, Table 8 and Table 9 Fig 5. calibration curve by HPLC 
Assay of Marketed Formulation
Amount of drugs present in the marketed formulation equations. Amount of APR found in the range from 99.99% and SD ± 0.015. 
Validation Parameters
This method was validated in accordance to ICH guidelines. Percentage of recoveries of APR was found in the range from 98.65 -101.69%. Precision of the method was determined by % RSD found among intra-day precision, inter-day precision. LOD and LOQ of APR were found to be 0.1646 and 0.4988 µg/ml, respectively. For robustness study, the effect of change in wavelength and flow rate ( ± 0.1 ml/min) on the Mean peak area, % RSD and % Assay were studied. Percentage RSD of each peak in all variables was found to be less than 2 %. 
